Microbicides Acceptability Among Sexually Active Young Women

ATN 062 will take place in parallel to another study, MTN 004, "Phase I Study of the Safety
and Acceptability of 3% w/w SPL7013 Gel (VivaGel™) Applied Vaginally in Sexually Active
Young Women." ATN 062 will use quantitative and qualitative research methods. The
quantitative method will consist of a computerized diary used by participants during the 14
days of the gel trial of MTN 004. The qualitative methods will include email messages sent
by participants to a research assistant as a supplement to the diaries, as well as in-depth
interviews through teleconferences to contextualize the recorded events. All study
activities will be timed to coincide with those of MTN 004

Inclusion Criteria:

- Currently enrolled in MTN 004.

- Willing and able to provide written informed consent for ATN 062.

- Willing to participate as required by protocol, including completion of all
assessments and follow-ups.

Exclusion Criteria:

- Refuses to have teleconferences audio recorded.

- Any social or medical condition that, in the investigator's opinion, would preclude
informed consent, make study participation unsafe, complicate interpretation of study
outcome data, or otherwise interfere with achieving the study objectives